(Pyr-6,Pro9)-Substance P (6-11) contains pyroglutamate at residue 6 and proline at residue 9, creating a sterically constrained signaling fragment. These substitutions enhance backbone rigidity and modulate hydrophobic interactions. Its short sequence assists in determining minimal motifs for tachykinin recognition. Researchers employ it in high-resolution structural and receptor-binding studies.
CAT No: S09047
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More